Bioidentical hormone micronized progesterone
- PMID: 22859638
- PMCID: PMC3395514
Bioidentical hormone micronized progesterone
Comment in
-
Bioidentical hormone therapy.Can Fam Physician. 2012 Dec;58(12):1334; author's reply p. 1334. Can Fam Physician. 2012. PMID: 23242886 Free PMC article. No abstract available.
References
-
- Greendale GA, Reboussin BA, Hogan P, Barnabei VM, Shumaker S, Johnson S, et al. Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial. Obstet Gynecol. 1998;92(6):982–8. - PubMed
-
- Lindenfeld EA, Langer RD. Bleeding patterns of the hormone replacement therapies in the postmenopausal estrogen and progestin interventions trial. Obstet Gynecol. 2002;100(5 Pt 1):853–63. - PubMed
-
- Fitzpatrick LA, Pace C, Wiita B. Comparison of regimens containing oral micronized progesterone or medroxyprogesterone acetate on quality of life in postmenopausal women: a cross-sectional survey. J Womens Health Gend Based Med. 2000;9(4):381–7. - PubMed
-
- Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA. 1995;273(3):199–208. - PubMed
-
- Canonico M, Oger E, Plu-Bureau G, Conard J, Meyer G, Lévesque H, et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens. Circulation. 2007;115(7):840–5. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources